Leg ulcers associated with factor V Leiden and prothrombin G20210A and methyltetrahydrofolate reductase mutations: successful treatment with warfarin.
Clivati Brandt
Hebert Roberto
HR
de Lorenzo Messina
Maria Cristina
MC
Belda Júnior
Walter
W
Costa Martins
Jose Eduardo
JE
Criado
Paulo Ricardo
PR
D017153:Antibodies, Anticardiolipin / Q000097:blood; D000925:Anticoagulants / Q000627:therapeutic use; D005165:Factor V; D005260:Female; D006579:Heterozygote; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D042965:Methylenetetrahydrofolate Reductase (NADPH2) / Q000235:genetics*; D008875:Middle Aged; D009154:Mutation; D011516:Prothrombin / Q000235:genetics*; D019851:Thrombophilia / Q000097:blood / Q000235:genetics*; D014859:Warfarin / Q000627:therapeutic use
D017153:Antibodies, Anticardiolipin; D000925:Anticoagulants; C095381:factor V Leiden; D014859:Warfarin; D005165:Factor V; D011516:Prothrombin; D042965:Methylenetetrahydrofolate Reductase (NADPH2)